Page last updated: 2024-09-05

enzastaurin and Squamous Cell Carcinoma of Head and Neck

enzastaurin has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayes, DN; Shores, CG; Yin, X	1
Ciaccio, MF; Cohen, EE; Jones, RB; Kuo, WL; Lingen, M; Liu, J; Rosner, MR; Seiwert, TY	1

Other Studies

2 other study(ies) available for enzastaurin and Squamous Cell Carcinoma of Head and Neck

Article	Year
Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma. Head & neck, 2011, Volume: 33, Issue:8 Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Disease Models, Animal; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Indoles; Mice; Mice, Nude; Neovascularization, Pathologic; Protein Kinase C; Protein Kinase C beta; Radiation-Sensitizing Agents; Random Allocation; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays	2011
Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin. Head & neck, 2011, Volume: 33, Issue:12 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; Head and Neck Neoplasms; In Situ Nick-End Labeling; Indoles; MAP Kinase Signaling System; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Sirolimus; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Tumor Cells, Cultured	2011

Article

Year

Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma.

Head & neck, 2011, Volume: 33, Issue:8

Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Disease Models, Animal; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Indoles; Mice; Mice, Nude; Neovascularization, Pathologic; Protein Kinase C; Protein Kinase C beta; Radiation-Sensitizing Agents; Random Allocation; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays

2011

Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin.

Head & neck, 2011, Volume: 33, Issue:12

Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; Head and Neck Neoplasms; In Situ Nick-End Labeling; Indoles; MAP Kinase Signaling System; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Sirolimus; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2011